Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Dittadi

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Anticancer Research|July 1, 1996
Dynamic use of tumor markers, rationale-clinical applications and pitfallsM Gion, R Mione, P Barioli, et al.
Clinical Chemistry|June 1, 1990
Radioligand binding assay of epidermal growth factor receptor: causes of variability and standardization of the assayR Dittadi, M Gion, A Brazzale, et al.
The International Journal of Biological Markers|January 14, 2005
The prognostic value of vascular endothelial growth factor, urokinase plasminogen activator and plasminogen activator inhibitor-1 in node-negative breast cancerS Meo, R Dittadi, L Peloso, et al.
Cancer Research|March 15, 1997
Detection of different estrogen receptor forms in breast cancer cytosol by enzyme immunoassayR Dittadi, S Meo, B Amoroso, et al.
The International Journal of Biological Markers|February 1, 2002
Evaluation of HER-2/neu in serum and tissue of primary and metastatic breast cancer patients using an automated enzyme immunoassayR Dittadi, M Zancan, A Perasole, et al.
Clinical Chemistry|May 1, 1999
Comparison of the diagnostic accuracy of CA27.29 and CA15.3 in primary breast cancerM Gion, R Mione, A E Leon, et al.
Cancer|February 1, 1989
A mucinous-like carcinoma-associated antigen (MCA) in the tissue and blood of patients with primary breast cancerE Bombardieri, M Gion, R Mione, et al.
The International Journal of Biological Markers|March 18, 1999
How tumor markers are used in the routine follow-up of breast and colorectal cancer. A survey of 29 Italian hospitalsM Gion, P Barioli, A Ponti, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Progesterone receptor determined by immunocytochemical and biochemical methods in human breast cancerG Gasparini, F Pozza, R Dittadi, et al.
Cancer|March 1, 1986
Carcinoembryonic antigen, ferritin, and tissue polypeptide antigen in serum and tissue. Relationship with the receptor content in breast carcinomaM Gion, R Mione, R Dittadi, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Anticancer Research|July 1, 1996
Dynamic use of tumor markers, rationale-clinical applications and pitfallsM Gion, R Mione, P Barioli, et al.
Clinical Chemistry|June 1, 1990
Radioligand binding assay of epidermal growth factor receptor: causes of variability and standardization of the assayR Dittadi, M Gion, A Brazzale, et al.
The International Journal of Biological Markers|January 14, 2005
The prognostic value of vascular endothelial growth factor, urokinase plasminogen activator and plasminogen activator inhibitor-1 in node-negative breast cancerS Meo, R Dittadi, L Peloso, et al.
Cancer Research|March 15, 1997
Detection of different estrogen receptor forms in breast cancer cytosol by enzyme immunoassayR Dittadi, S Meo, B Amoroso, et al.
The International Journal of Biological Markers|February 1, 2002
Evaluation of HER-2/neu in serum and tissue of primary and metastatic breast cancer patients using an automated enzyme immunoassayR Dittadi, M Zancan, A Perasole, et al.
Clinical Chemistry|May 1, 1999
Comparison of the diagnostic accuracy of CA27.29 and CA15.3 in primary breast cancerM Gion, R Mione, A E Leon, et al.
Cancer|February 1, 1989
A mucinous-like carcinoma-associated antigen (MCA) in the tissue and blood of patients with primary breast cancerE Bombardieri, M Gion, R Mione, et al.
The International Journal of Biological Markers|March 18, 1999
How tumor markers are used in the routine follow-up of breast and colorectal cancer. A survey of 29 Italian hospitalsM Gion, P Barioli, A Ponti, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Progesterone receptor determined by immunocytochemical and biochemical methods in human breast cancerG Gasparini, F Pozza, R Dittadi, et al.
Cancer|March 1, 1986
Carcinoembryonic antigen, ferritin, and tissue polypeptide antigen in serum and tissue. Relationship with the receptor content in breast carcinomaM Gion, R Mione, R Dittadi, et al.
Pageof 5